Patient-reported communications with pharmacy staff at community pharmacies: the Alabama NSAID Patient Safety Study, 2005-2007
Authors
LaCivita, Cynthia L.Funkhouser, Ellen M.
Miller, Michael J.
Ray, Midge N.
Saag, Kenneth G.
Kiefe, Catarina I.
Cobaugh, Daniel J.
Allison, Jeroan J.
UMass Chan Affiliations
Department of Quantitative Health SciencesDocument Type
Journal ArticlePublication Date
2010-08-28Keywords
African AmericansAlabama
*Anti-Inflammatory Agents, Non-Steroidal
effects
Arthritis
*Communication
Cross-Sectional Studies
Drug Toxicity
European Continental Ancestry Group
Female
Humans
Male
Middle Aged
Nonprescription Drugs
Pain
*Pharmacies
*Pharmacists
Prescription Drugs
*Professional-Patient Relations
Risk Assessment
Bioinformatics
Biostatistics
Epidemiology
Health Services Research
Metadata
Show full item recordAbstract
OBJECTIVES: To examine the prevalence of patient-pharmacy staff communication about medications for pain and arthritis and to assess disparities in communication by demographic, socioeconomic, and health indicators. DESIGN: Descriptive, nonexperimental, cross-sectional study. SETTING: Alabama between 2005 and 2007. PATIENTS: 687 Patients participating in the Alabama NSAID Patient Safety Study (age >or=50 years and currently taking a prescription nonsteroidal anti-inflammatory drug [NSAID]). INTERVENTION: Not applicable. MAIN OUTCOME MEASURES: Communication with pharmacy staff about prescription and over-the-counter (OTC) NSAIDs was examined before and after adjustment for demographic, socioeconomic, and health indicators. RESULTS: For the entire cohort (n = 687), mean (+/-SD) age was 68.3 +/- 10.0 years, 72.8% were women, 36.4% were black, and 31.2% discussed use of prescription pain/arthritis medications with pharmacy staff. Discussing use of prescription pain/arthritis medications with pharmacy staff differed by race/gender (P < 0.001): white men (40.3%), white women (34.6%), black men (30.2%), and black women (19.8%). Even after multivariable adjustment, black women had the lowest odds of discussing their medications with pharmacy staff (odds ratio 0.40 [95% CI 0.24-0.56]) compared with white men. For the 63.0% of participants with recently overlapping prescription and OTC NSAID use, communication with pharmacy staff about OTC NSAIDs use was only 13.7% and did not vary significantly by race/gender group. CONCLUSION: Given the complex risks and benefits of chronic NSAID use, pharmacists, pharmacy staff, and patients all are missing an important opportunity to avoid unsafe prescribing and decrease medication adverse events.Source
J Am Pharm Assoc. 2009 Sep-Oct;49(5):e110-7. Link to article on publisher's siteDOI
10.1331/JAPhA.2009.09005Permanent Link to this Item
http://hdl.handle.net/20.500.14038/47766PubMed ID
20797933Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1331/JAPhA.2009.09005